Follow-up Study of Safety and Efficacy in Subjects Who Completed PNEUMOSTEM® Phase II (MP-CR-012) Clinical Trial

NCT04003857 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Bronchopulmonary Dysplasia
BPD

Interventions

BIOLOGICAL: PNEUMOSTEM®
BIOLOGICAL: normal saline

Sponsor

Medipost Co Ltd.